Myeloproliferative disorders, Blood, vol.112, issue.6, pp.2190-2198, 2008. ,
DOI : 10.1182/blood-2008-03-077966
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders, The Lancet, vol.365, issue.9464, pp.1054-61, 2005. ,
DOI : 10.1016/S0140-6736(05)74230-6
MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia, PLoS Medicine, vol.102, issue.7, p.270, 2006. ,
DOI : 10.1371/journal.pmed.0030270.st001
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms, New England Journal of Medicine, vol.369, issue.25, pp.2379-90, 2013. ,
DOI : 10.1056/NEJMoa1311347
Clinical utility gene card for: Hereditary thrombocythemia, European Journal of Human Genetics, vol.92, issue.2, pp.1-5, 2014. ,
DOI : 10.1038/sj.leu.2404846
Mutation in a Family with Hereditary Thrombocytosis, New England Journal of Medicine, vol.366, issue.10, pp.967-976, 2012. ,
DOI : 10.1056/NEJMc1200349
Impact of isolated germline JAK2V617I mutation on human hematopoiesis, Blood, vol.121, issue.20, pp.4156-65, 2013. ,
DOI : 10.1182/blood-2012-05-430926
JAK mutations in high-risk childhood acute lymphoblastic leukemia, Proceedings of the National Academy of Sciences, vol.106, issue.23, pp.9414-9422, 2009. ,
DOI : 10.1073/pnas.0811761106
The Leptin Receptor Activates Janus Kinase 2 and Signals for Proliferation in a Factor-Dependent Cell Line, Molecular Endocrinology, vol.11, issue.4, pp.393-402, 1997. ,
DOI : 10.1210/mend.11.4.9907
Signaling via JAK tyrosine kinases: growth hormone receptor as a model system, Recent Prog Horm Res, vol.53, pp.61-82, 1998. ,
Association of common variants in JAK2 gene with reduced risk of metabolic syndrome and related disorders, BMC Medical Genetics, vol.55, issue.4, p.166, 2011. ,
DOI : 10.2337/diabetes.55.04.06.db05-1265
Mutation Profile of JAK2 Transcripts in Patients with Chronic Myeloproliferative Neoplasias, The Journal of Molecular Diagnostics, vol.11, issue.1, pp.49-53, 2009. ,
DOI : 10.2353/jmoldx.2009.080114
Tyrosine Phosphorylation of Jak2 in the JH2 Domain Inhibits Cytokine Signaling, Molecular and Cellular Biology, vol.24, issue.11, pp.4968-78, 2004. ,
DOI : 10.1128/MCB.24.11.4968-4978.2004
Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms, Blood, vol.127, issue.3, pp.325-357, 2016. ,
DOI : 10.1182/blood-2015-07-661835
A report on the co-occurrence of JAK2V617F and CALR mutations in myeloproliferative neoplasm patients, Annals of Hematology, vol.14, issue.10, pp.865-872, 2015. ,
DOI : 10.1007/s00277-014-2248-0